(2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid

C167H265N53O14 — CID 158331837

About (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid

(2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid (PubChem CID 158331837) has the molecular formula C167H265N53O14 and a molecular weight of 3239.31 g/mol. Its IUPAC name is (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid.

Molecular Properties

• Compound Name: (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid
• PubChem CID: 158331837
• Molecular Formula: C167H265N53O14
• Molecular Weight: 3239.31 g/mol
• Exact Mass: 3237.17
• IUPAC Name: (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid
• SMILES: CN(c1nc(NCc2cn(CCCNCCCNC3CCCCC3)nn2)nc2ccccc12)C1CCN(C(=O)CC[C@H](N)C(=O)O)CC1.Cc1cc(NC2CCN(CCCCC(=O)O)CC2)nc(NCc2cn(CCCNCCCNC3CCCCC3)nn2)n1.NC(CCC(=O)N1CCC(Nc2nc(NCCn3cc(CCCNCCCCC4CCCCC4)nn3)nc3ccccc23)CC1)C(=O)O.N[C@@H](CC(=O)N1CCC(Nc2nc(NCc3cn(CCCNCCCNC4CCCCC4)nn3)nc3ccccc23)CC1)C(=O)O.N[C@@H](CCC(=O)CCCN1CCC(Nc2nc(NCc3cn(CCCNCCCNC4CCCCC4)nn3)nc3ccccc23)CC1)C(=O)O
• InChI: InChI=1S/C36H57N11O3.C35H54N10O3.C34H53N11O3.C32H49N11O3.C30H52N10O2/c37-32(35(49)50)15-14-30(48)11-6-21-46-23-16-28(17-24-46)41-34-31-12-4-5-13-33(31)42-36(43-34)40-25-29-26-47(45-44-29)22-8-19-38-18-7-20-39-27-9-2-1-3-10-27;36-30(34(47)48)15-16-32(46)44-22-17-27(18-23-44)39-33-29-13-4-5-14-31(29)40-35(41-33)38-21-24-45-25-28(42-43-45)12-8-20-37-19-7-6-11-26-9-2-1-3-10-26;1-43(27-15-21-44(22-16-27)31(46)14-13-29(35)33(47)48)32-28-11-5-6-12-30(28)39-34(40-32)38-23-26-24-45(42-41-26)20-8-18-36-17-7-19-37-25-9-3-2-4-10-25;33-27(31(45)46)20-29(44)42-18-12-24(13-19-42)37-30-26-10-4-5-11-28(26)38-32(39-30)36-21-25-22-43(41-40-25)17-7-15-34-14-6-16-35-23-8-2-1-3-9-23;1-24-21-28(35-26-12-19-39(20-13-26)17-6-5-11-29(41)42)36-30(34-24)33-22-27-23-40(38-37-27)18-8-15-31-14-7-16-32-25-9-3-2-4-10-25/h4-5,12-13,26-28,32,38-39H,1-3,6-11,14-25,37H2,(H,49,50)(H2,40,41,42,43);4-5,13-14,25-27,30,37H,1-3,6-12,15-24,36H2,(H,47,48)(H2,38,39,40,41);5-6,11-12,24-25,27,29,36-37H,2-4,7-10,13-23,35H2,1H3,(H,47,48)(H,38,39,40);4-5,10-11,22-24,27,34-35H,1-3,6-9,12-21,33H2,(H,45,46)(H2,36,37,38,39);21,23,25-26,31-32H,2-20,22H2,1H3,(H,41,42)(H2,33,34,35,36)/t32-;;29-;27-;/m0.00./s1
• InChIKey: GQCLCLJQOSAVHL-KZBGTSBVSA-N
• XLogP: 16.23
• TPSA: 877.29 Ų
• H-Bond Donors: 27
• H-Bond Acceptors: 59
• Rotatable Bonds: 95
• Heavy Atoms: 234
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	3239.31
LogP ≤ 5	16.23
H-Bond Donors ≤ 5	27
H-Bond Acceptors ≤ 10	59

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid?

The IUPAC name of (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid (CID 158331837) is (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid.

What is the SMILES notation for (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid?

The canonical SMILES for (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid is CN(c1nc(NCc2cn(CCCNCCCNC3CCCCC3)nn2)nc2ccccc12)C1CCN(C(=O)CC[C@H](N)C(=O)O)CC1.Cc1cc(NC2CCN(CCCCC(=O)O)CC2)nc(NCc2cn(CCCNCCCNC3CCCCC3)nn2)n1.NC(CCC(=O)N1CCC(Nc2nc(NCCn3cc(CCCNCCCCC4CCCCC4)nn3)nc3ccccc23)CC1)C(=O)O.N[C@@H](CC(=O)N1CCC(Nc2nc(NCc3cn(CCCNCCCNC4CCCCC4)nn3)nc3ccccc23)CC1)C(=O)O.N[C@@H](CCC(=O)CCCN1CCC(Nc2nc(NCc3cn(CCCNCCCNC4CCCCC4)nn3)nc3ccccc23)CC1)C(=O)O.

What is the InChIKey of (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid?

The InChIKey is GQCLCLJQOSAVHL-KZBGTSBVSA-N. The full InChI is InChI=1S/C36H57N11O3.C35H54N10O3.C34H53N11O3.C32H49N11O3.C30H52N10O2/c37-32(35(49)50)15-14-30(48)11-6-21-46-23-16-28(17-24-46)41-34-31-12-4-5-13-33(31)42-36(43-34)40-25-29-26-47(45-44-29)22-8-19-38-18-7-20-39-27-9-2-1-3-10-27;36-30(34(47)48)15-16-32(46)44-22-17-27(18-23-44)39-33-29-13-4-5-14-31(29)40-35(41-33)38-21-24-45-25-28(42-43-45)12-8-20-37-19-7-6-11-26-9-2-1-3-10-26;1-43(27-15-21-44(22-16-27)31(46)14-13-29(35)33(47)48)32-28-11-5-6-12-30(28)39-34(40-32)38-23-26-24-45(42-41-26)20-8-18-36-17-7-19-37-25-9-3-2-4-10-25;33-27(31(45)46)20-29(44)42-18-12-24(13-19-42)37-30-26-10-4-5-11-28(26)38-32(39-30)36-21-25-22-43(41-40-25)17-7-15-34-14-6-16-35-23-8-2-1-3-9-23;1-24-21-28(35-26-12-19-39(20-13-26)17-6-5-11-29(41)42)36-30(34-24)33-22-27-23-40(38-37-27)18-8-15-31-14-7-16-32-25-9-3-2-4-10-25/h4-5,12-13,26-28,32,38-39H,1-3,6-11,14-25,37H2,(H,49,50)(H2,40,41,42,43);4-5,13-14,25-27,30,37H,1-3,6-12,15-24,36H2,(H,47,48)(H2,38,39,40,41);5-6,11-12,24-25,27,29,36-37H,2-4,7-10,13-23,35H2,1H3,(H,47,48)(H,38,39,40);4-5,10-11,22-24,27,34-35H,1-3,6-9,12-21,33H2,(H,45,46)(H2,36,37,38,39);21,23,25-26,31-32H,2-20,22H2,1H3,(H,41,42)(H2,33,34,35,36)/t32-;;29-;27-;/m0.00./s1.

What are the key properties of (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid?

(2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid has a molecular weight of 3239.31 g/mol, XLogP of 16.23, 95 rotatable bonds, 27 hydrogen bond donors, and 59 hydrogen bond acceptors.

Where does this data come from?

All data for (2S)-2-amino-4-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-4-oxobutanoic acid;(2S)-2-amino-8-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxooctanoic acid;(2S)-2-amino-5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]quinazolin-4-yl]-methylamino]piperidin-1-yl]-5-oxopentanoic acid;2-amino-5-[4-[[2-[2-[4-[3-(4-cyclohexylbutylamino)propyl]triazol-1-yl]ethylamino]quinazolin-4-yl]amino]piperidin-1-yl]-5-oxopentanoic acid;5-[4-[[2-[[1-[3-[3-(cyclohexylamino)propylamino]propyl]triazol-4-yl]methylamino]-6-methylpyrimidin-4-yl]amino]piperidin-1-yl]pentanoic acid is sourced from PubChem (CID 158331837), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).